Catalyst overview
Research summary
This catalyst tracks a Phase 1/2 data readout for Z-1018 (adjuvanted w/ CpG 1018) in Shingles Vaccine. The expected timing is based on the latest available company guidance and may change.
6/27/24- First participant dosed. 8/21/25- Topline results from Part 1 reported. Select optimal dose for advancement to Part 2 & initiate in H2 2025. 10/21/25- Presentation at IDWeek'25. 11/05/25:- Positive Part 1 Ph1/2 shingles data presented at IDWeek; Part 2 dosing begun; H2 2026 results expected.
Verification
Confirm timing and program details against the company announcement or filing.